Merck & Co (MRK) investors who suffered losses can take the lead in securities fraud lawsuit
Investors who have suffered losses as a result of their involvement with Merck & Co, also known as Merck, now have the chance to take the lead in a securities fraud lawsuit. This announcement comes from national securities litigation firm Kaskela Law LLC, which is encouraging investors who have incurred losses to contact the firm to discuss their legal rights and potential opportunities for establishing a lead plaintiff position.
The securities fraud class action lawsuit in question has been filed against Merck on behalf of investors who purchased or acquired the company’s securities between February 5, 2013, and February 3, 2021. This lawsuit is being pursued in the United States District Court for the District of New Jersey.
The lawsuit alleges that Merck made false and misleading statements to investors regarding the efficacy of the Company’s cholesterol treatment drug, Zetia, and its effectiveness in reducing cardiovascular events in patients with atherosclerosis. According to the lawsuit, Merck’s statements were misleading because they failed to disclose that the clinical studies supporting Zetia’s efficacy misrepresented the drug’s safety profile.
As a result of these alleged misrepresentations, the lawsuit claims that Merck’s share price was inflated. When the truth regarding Zetia’s safety profile and efficacy came to light, the lawsuit states that Merck’s share price declined, causing financial harm to investors who had purchased the company’s securities during the specified time period.
Investors who wish to be considered for appointment as a lead plaintiff in this securities fraud class action lawsuit must submit an application by May 10, 2021. To be eligible for consideration as a lead plaintiff, investors must meet certain requirements set forth by the court, including actively monitoring their investment in Merck and making decisions regarding legal counsel within a reasonable timeframe.
Kaskela Law LLC is a national securities litigation firm that represents investors in securities fraud, corporate governance, and merger and acquisition cases. The firm is dedicated to providing high-quality legal representation to investors who have suffered financial losses due to securities fraud or other corporate misconduct. The firm’s attorneys have extensive experience in securities litigation and are committed to seeking justice for investors who have been wronged by deceptive corporate practices.
